UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia

Clinical cancer research, 2018-12, Vol.24 (24), p.6185-6194

2018

Volltextzugriff (PDF)

Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy

Cancer Immunology and Immunotherapy, 2021-10, Vol.70 (10), p.2851-2865

2021

Volltextzugriff (PDF)

Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML

Clinical cancer research, 2018-04, Vol.24 (8), p.1834-1844

2018

Volltextzugriff (PDF)

Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma Patients

Clinical cancer research, 2023-10, Vol.29 (20), p.4139-4152

2023

Volltextzugriff (PDF)

Third Generation CD19-CAR T Cells for Relapsed and Refractory Lymphoma and Leukemia Report from the Swedish Phase I/IIa Trial

Blood, 2015-12, Vol.126 (23), p.1534-1534

2015

Volltextzugriff (PDF)

Design and synthesis of potent hydroxyethylamine (HEA) BACE-1 inhibitors carrying prime side 4,5,6,7-tetrahydrobenzazole and 4,5,6,7-tetrahydropyridinoazole templates

Bioorganic & medicinal chemistry letters, 2012-11, Vol.22 (21), p.6721-6727

2012

Volltextzugriff (PDF)

Synthesis and SAR of potent inhibitors of the Hepatitis C virus NS3/4A protease: Exploration of P2 quinazoline substituents

Bioorganic & medicinal chemistry letters, 2010-07, Vol.20 (14), p.4004-4011

2010

Volltextzugriff (PDF)

748. A Clinical Trial Using Third Generation CD19 Targeting CAR T Cells for Relapsed Lymphoma and Leukemia

Molecular therapy, 2016-05, Vol.24, p.S295-S296

2016

Volltextzugriff (PDF)

Discovery of 4′-azido-2′-deoxy-2′-C-methyl cytidine and prodrugs thereof: A potent inhibitor of Hepatitis C virus replication

Bioorganic & medicinal chemistry letters, 2012-05, Vol.22 (9), p.3265-3268

2012

Volltextzugriff (PDF)

Abstract A041: CD19-targeting third generation CAR T cells for relapsed and refractory lymphoma and leukemia – report from the Swedish phase I/IIa trial

Cancer immunology research, 2016-01, Vol.4 (1_Supplement), p.A041-A041

2016

Volltextzugriff (PDF)

Discovery of novel, potent and bioavailable proline-urea based macrocyclic HCV NS3/4A protease inhibitors

Bioorganic & medicinal chemistry, 2008-12, Vol.18 (23), p.6189-6193

2008

Volltextzugriff (PDF)

Abstract 1793: Single-cell RNA analysis reveal effector-like CD8+ CAR-T cell subpopulations associated with response in lymphoma patients

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.1793-1793

2023

Volltextzugriff (PDF)

A Clinical Trial Using Third Generation CD19 Targeting CAR T Cells for Relapsed Lymphoma and Leukemia

Molecular therapy, 2016, Vol.24, p.S295

2016

Volltextzugriff (PDF)

A second, expressed thrombospondin gene (Thbs2) exists in the mouse genome

The Journal of biological chemistry, 1991-07, Vol.266 (20), p.12821-12824

1991

Volltextzugriff (PDF)

CD19-targeting third generation CAR T cells for relapsed and refractory lymphoma and leukemia: report from the Swedish phase Ulla trial

Cancer immunology research, 2016, Vol.4 (1)

2016

Volltextzugriff (PDF)

Clinical Grade Vector Production: Analysis of Yield, Stability, and Storage of GMP-Produced Retroviral Vectors for Gene Therapy

Biotechnology progress, 2004-07, Vol.20 (4), p.1198-1203

2004

Volltextzugriff (PDF)

MIV-170, a Novel NNRTI With Potent Activity Against HIV and HIV Mutants

Antiviral research, 2008-05, Vol.78 (2), p.A51-A51

2008

Volltextzugriff (PDF)

Modulation of thrombospondin expression during differentiation of embryonal carcinoma cells

Journal of cellular physiology, 1994-03, Vol.158 (3), p.495-505

1994

Volltextzugriff (PDF)

Characterization of protein kinase C-mediated phosphorylation of the short cytoplasmic domain isoform of C-CAM

FEBS letters, 1998-03, Vol.425 (1), p.166-170

1998

Volltextzugriff (PDF)

Homophilic Intercellular Adhesion Mediated by C-CAM Is Due to a Domain 1–Domain 1 Reciprocal Binding

Experimental cell research, 1996-09, Vol.227 (2), p.360-366

1996

Volltextzugriff (PDF)

Cell adhesion activity of the short cytoplasmic domain isoform of C-CAM (C-CAM2) in CHO cells

FEBS letters, 1995-05, Vol.365 (1), p.51-56

1995

Volltextzugriff (PDF)

An Academic Centre for Gene Therapy Research with Clinical Grade Manufacturing Capability

Annals of medicine (Helsinki), 1997, Vol.29 (6), p.579-583

1997

Volltextzugriff (PDF)

A bleeding model in rabbits demonstrate fresh clot selectivity for a genetically engineered variant of tissue-type plasminogen activator and for streptokinase

Thrombosis research, 1993-05, Vol.70 (3), p.217-224

1993

Volltextzugriff (PDF)

Identification of Novel Glycans in the Mucus Layer of Shark and Skate Skin

International journal of molecular sciences, 2023-09, Vol.24 (18), p.14331

2023

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(56)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia

Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy

Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML

Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma Patients

Adaptive single-KIR+NKG2C+ NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia

Third Generation CD19-CAR T Cells for Relapsed and Refractory Lymphoma and Leukemia Report from the Swedish Phase I/IIa Trial

Design and synthesis of potent hydroxyethylamine (HEA) BACE-1 inhibitors carrying prime side 4,5,6,7-tetrahydrobenzazole and 4,5,6,7-tetrahydropyridinoazole templates

Synthesis and SAR of potent inhibitors of the Hepatitis C virus NS3/4A protease: Exploration of P2 quinazoline substituents

748. A Clinical Trial Using Third Generation CD19 Targeting CAR T Cells for Relapsed Lymphoma and Leukemia

Discovery of 4′-azido-2′-deoxy-2′-C-methyl cytidine and prodrugs thereof: A potent inhibitor of Hepatitis C virus replication

Abstract A041: CD19-targeting third generation CAR T cells for relapsed and refractory lymphoma and leukemia – report from the Swedish phase I/IIa trial

Discovery of novel, potent and bioavailable proline-urea based macrocyclic HCV NS3/4A protease inhibitors

Abstract 1793: Single-cell RNA analysis reveal effector-like CD8+ CAR-T cell subpopulations associated with response in lymphoma patients

A Clinical Trial Using Third Generation CD19 Targeting CAR T Cells for Relapsed Lymphoma and Leukemia

A second, expressed thrombospondin gene (Thbs2) exists in the mouse genome

CD19-targeting third generation CAR T cells for relapsed and refractory lymphoma and leukemia: report from the Swedish phase Ulla trial

Clinical Grade Vector Production: Analysis of Yield, Stability, and Storage of GMP-Produced Retroviral Vectors for Gene Therapy

MIV-170, a Novel NNRTI With Potent Activity Against HIV and HIV Mutants

Modulation of thrombospondin expression during differentiation of embryonal carcinoma cells

Characterization of protein kinase C-mediated phosphorylation of the short cytoplasmic domain isoform of C-CAM

Homophilic Intercellular Adhesion Mediated by C-CAM Is Due to a Domain 1–Domain 1 Reciprocal Binding

Cell adhesion activity of the short cytoplasmic domain isoform of C-CAM (C-CAM2) in CHO cells

An Academic Centre for Gene Therapy Research with Clinical Grade Manufacturing Capability

A bleeding model in rabbits demonstrate fresh clot selectivity for a genetically engineered variant of tissue-type plasminogen activator and for streptokinase

Identification of Novel Glycans in the Mucus Layer of Shark and Skate Skin

Suchergebnisse filtern